Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mass Screening | 2 | 2016 | 675 | 0.180 |
Why?
|
| Behavioral Medicine | 2 | 2016 | 5 | 0.160 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 1043 | 0.140 |
Why?
|
| Patient Navigation | 1 | 2016 | 17 | 0.130 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 471 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2016 | 353 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 369 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 542 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 443 | 0.090 |
Why?
|
| Electric Injuries | 3 | 1999 | 21 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2686 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 1999 | 474 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 2395 | 0.050 |
Why?
|
| Burns, Electric | 2 | 1999 | 5 | 0.040 |
Why?
|
| Poloxamer | 1 | 1999 | 29 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 1999 | 60 | 0.040 |
Why?
|
| Immunochemistry | 1 | 2016 | 18 | 0.030 |
Why?
|
| Societies | 1 | 2016 | 16 | 0.030 |
Why?
|
| Occult Blood | 1 | 2016 | 28 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2016 | 55 | 0.030 |
Why?
|
| Awareness | 1 | 2016 | 89 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 191 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 84 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 6916 | 0.030 |
Why?
|
| Program Development | 1 | 2016 | 130 | 0.030 |
Why?
|
| Minority Groups | 1 | 2016 | 152 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 1995 | 36 | 0.030 |
Why?
|
| Poverty | 1 | 2016 | 189 | 0.030 |
Why?
|
| Aged | 3 | 2016 | 19946 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 348 | 0.030 |
Why?
|
| Gamma Cameras | 1 | 1994 | 2 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2016 | 301 | 0.030 |
Why?
|
| Health Personnel | 1 | 2016 | 223 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1994 | 102 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 488 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1994 | 97 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2016 | 265 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 27048 | 0.020 |
Why?
|
| Decision Making | 1 | 2016 | 680 | 0.020 |
Why?
|
| Necrosis | 2 | 1999 | 209 | 0.020 |
Why?
|
| Humans | 6 | 2016 | 92335 | 0.020 |
Why?
|
| Female | 4 | 2016 | 47910 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 1228 | 0.010 |
Why?
|
| United States | 1 | 2016 | 7366 | 0.010 |
Why?
|
| Male | 2 | 2016 | 43922 | 0.010 |
Why?
|
| Rats | 2 | 1999 | 4063 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1999 | 119 | 0.010 |
Why?
|
| Hindlimb | 1 | 1999 | 96 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 997 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 683 | 0.010 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 1995 | 9 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 53 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1994 | 11 | 0.010 |
Why?
|
| Miniaturization | 1 | 1994 | 14 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1994 | 217 | 0.010 |
Why?
|
| Muscles | 1 | 1994 | 190 | 0.010 |
Why?
|
| Cell Survival | 1 | 1995 | 1008 | 0.010 |
Why?
|
| Equipment Design | 1 | 1994 | 420 | 0.010 |
Why?
|
| Animals | 3 | 1999 | 28055 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 2445 | 0.000 |
Why?
|